AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

AEterna Zentaris Enters Into a License and Collaboration Agreement With Tulane University for a Novel Class of Potential Anti-Cancer Agents - Growth Hormone Releasing Hormone Antagonists.

PR Newswire Europe

| October 27, 2004 | COPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

QUEBEC, Canada, October 27 /PRNewswire/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS) today announced that it has entered into a license and collaboration agreement with Tulane University, in New Orleans, for the development of Growth Hormone Releasing Hormone (GH-RH) antagonists, a novel class of potential anti-cancer agents.

Under the terms of the agreement, AEterna Zentaris obtained worldwide, exclusive rights to develop and commercialise GH-RH antagonists for all potential indications, including cancer and endocrine disorders, in exchange for research funding, an upfront fee and milestone payments, in addition to royalties on future sales.

GH-RH antagonists represent a potential novel class of promising anti-cancer agents that may offer distinct advantages as compared to other classes of anti-tumor agents, with utility in a variety of tumor types. In addition to their ability to exert…

Related articles from newspapers, magazines, journals, and more
AEterna Zentaris Enters into a License and Collaboration Agreement with Tulane...
Press release article from: PR Newswire October 27, 2004 700+ words
AEterna Zentaris Inc. (TSX...agreement with Tulane University, in New Orleans...Officer at AEterna Zentaris. "We are...collaboration with AEterna Zentaris," said Prof...Medicine at Tulane University. "GH-RH...
AEterna Zentaris Advances AN-152 Targeted Anti-Cancer Agent into Clinical...
Press release article from: PR Newswire January 18, 2005 700+ words
...Schally at Tulane University in New Orleans...and COO of AEterna Zentaris. AN-152...cell lines. AEterna Zentaris has in...152 from Tulane University. AN-152...somatostatin. About AEterna Zentaris Inc. AEterna...
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights for Cetrorelix...
Press release article from: PR Newswire January 30, 2006 700+ words
...endometriosis, while AEterna Zentaris intends to pursue...Executive Officer at AEterna Zentaris. "Regaining the...Andrew Schally of Tulane University in New Orleans...countries. About AEterna Zentaris Inc. AEterna Zentaris...
AEterna Zentaris Announces Details of Distribution of its Remaining Shares of...
Press release article from: PR Newswire October 25, 2006 700+ words
...25 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS...of Atrium Biotechnologies held by AEterna Zentaris by way of reduction of the stated capital of AEterna Zentaris' common shares. AEterna Zentaris...
AEterna Zentaris Shareholders Approve Reduction in Stated Capital and...
Press release article from: PR Newswire December 15, 2006 700+ words
...15 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS...Biotechnologies Inc. (TSX: ATB) held by AEterna Zentaris at the special meeting of shareholders...shareholders, the board of directors of AEterna Zentaris determined that the distribution date...
AEterna Zentaris Enters a License and Collaboration Agreement with Spectrum...
Press release article from: PR Newswire August 12, 2004 700+ words
...All amounts are in Canadian dollars AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS...The agreement comes on the heels of AEterna Zentaris regaining worldwide rights to D...Under the terms of the agreement, AEterna Zentaris granted to Spectrum an exclusive license...
AEterna Zentaris Strengthens its Position in the Development of Innovative...
Press release article from: PR Newswire January 6, 2005 700+ words
...Erucylphosphocholine (ErPC) AEterna Zentaris Inc. (TSX: AEZ; Nasdaq...At today's closing, AEterna Zentaris paid US$2.7 million by...443,905 common shares of AEterna Zentaris at US$6.11 per share...
/C O R R E C T I O N from Source -- AEterna Zentaris Inc./.
Press release article from: PR Newswire October 25, 2006 700+ words
...Notice. Corrected copy follows: AEterna Zentaris Announces Details of Distribution...25 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS...of Atrium Biotechnologies held by AEterna Zentaris by way of reduction of the stated...
Aeterna Zentaris appoints Jurgen Ernst Chairman of the Board of Directors and...
Press release article from: PR Newswire August 14, 2007 700+ words
...PRNewswire-FirstCall/ -- Aeterna Zentaris Inc. (TSX: AEZ; NASDAQ...Jurgen Ernst, Chairman of Aeterna Zentaris, stated, "Dr. Dupont...growth and evolution of Aeterna Zentaris have proven to be invaluable...
AEterna Zentaris Announces Research Project with the University of Montreal on...
Press release article from: PR Newswire May 3, 2006 700+ words
...May 3 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS...development of novel treatment for obesity. AEterna Zentaris developed many small orally-bioavailable...which will enable to identify those AEterna Zentaris molecules which antagonize the effect...
For more facts and information, see all results

Source: HighBeam Research, AEterna Zentaris Enters Into a License and Collaboration Agreement...

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily